Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

NCT03907046 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Intracerebral Hemorrhage
Atrial Fibrillation

Interventions

DRUG: Apixaban
DRUG: Aspirin

Sponsor

Yale University

Collaborators

[object Object]